US2004033947A1PendingUtilityA1

Method for treating hemophilia b

47
Priority: Nov 8, 2001Filed: Nov 8, 2001Published: Feb 19, 2004
Est. expiryNov 8, 2021(expired)· nominal 20-yr term from priority
Inventors:Jan OhrstromLynn RosePaul D. Bishop
A61K 38/45A61K 38/4846A61K 38/36
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Use of factor XIII for treating hemophilia B. A patient having hemophilia B is treated by administering factor XIII generally in conjunction with factor IX.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method for treating hemophilia B in an individual comprising administering factor XIII to said individual.  
     
     
         2 . The method of  claim 1  wherein the factor XIII is administered at a dosage of 0.45 U/kg to raise the factor XIII by 1%.  
     
     
         3 . A method for treating hemophilia B comprising administering factor XIII in conjunction with factor IX.  
     
     
         4 . The method of  claim 3  wherein the factor XIII is administered at a dosage of 0.45 U/kg to raise the factor XIII by 1%.  
     
     
         5 . The use of factor XIII for the production of a medicament for the treatment of hemophilia B.

Join the waitlist — get patent alerts

Track US2004033947A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.